KR950703515A - 신규 n,n,n',n'-2치환-1,2-에탄디아민 유도체 화합물(new n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds) - Google Patents

신규 n,n,n',n'-2치환-1,2-에탄디아민 유도체 화합물(new n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds) Download PDF

Info

Publication number
KR950703515A
KR950703515A KR1019950701049A KR19950701049A KR950703515A KR 950703515 A KR950703515 A KR 950703515A KR 1019950701049 A KR1019950701049 A KR 1019950701049A KR 19950701049 A KR19950701049 A KR 19950701049A KR 950703515 A KR950703515 A KR 950703515A
Authority
KR
South Korea
Prior art keywords
compound
group
general formula
formula
pfc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019950701049A
Other languages
English (en)
Korean (ko)
Inventor
라파엘 포겟
산티에고 구베르트
조세 오티즈
오레리오 사크리스탄
조셉 엠. 카스텔로
Original Assignee
라파엘 포겟
페레르 인터내쇼날, 에스. 에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라파엘 포겟, 페레르 인터내쇼날, 에스. 에이. filed Critical 라파엘 포겟
Publication of KR950703515A publication Critical patent/KR950703515A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/04—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
    • C07C225/06—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and acyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019950701049A 1993-07-19 1994-07-18 신규 n,n,n',n'-2치환-1,2-에탄디아민 유도체 화합물(new n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds) Withdrawn KR950703515A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SEP9301616 1993-07-19
ES09301616A ES2074946B1 (es) 1993-07-19 1993-07-19 Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
PCT/EP1994/002363 WO1995003270A1 (en) 1993-07-19 1994-07-18 New n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds

Publications (1)

Publication Number Publication Date
KR950703515A true KR950703515A (ko) 1995-09-20

Family

ID=8282595

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701049A Withdrawn KR950703515A (ko) 1993-07-19 1994-07-18 신규 n,n,n',n'-2치환-1,2-에탄디아민 유도체 화합물(new n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds)

Country Status (19)

Country Link
US (1) US5561135A (cg-RX-API-DMAC7.html)
EP (1) EP0660819B1 (cg-RX-API-DMAC7.html)
JP (1) JPH08503962A (cg-RX-API-DMAC7.html)
KR (1) KR950703515A (cg-RX-API-DMAC7.html)
AT (1) ATE159511T1 (cg-RX-API-DMAC7.html)
AU (1) AU670716B2 (cg-RX-API-DMAC7.html)
CA (1) CA2144758A1 (cg-RX-API-DMAC7.html)
DE (1) DE69406406T2 (cg-RX-API-DMAC7.html)
DK (1) DK0660819T3 (cg-RX-API-DMAC7.html)
ES (1) ES2074946B1 (cg-RX-API-DMAC7.html)
FI (1) FI951277L (cg-RX-API-DMAC7.html)
GR (1) GR3025941T3 (cg-RX-API-DMAC7.html)
MX (1) MX9403011A (cg-RX-API-DMAC7.html)
NO (1) NO950974L (cg-RX-API-DMAC7.html)
NZ (1) NZ271076A (cg-RX-API-DMAC7.html)
PH (1) PH30969A (cg-RX-API-DMAC7.html)
TW (1) TW262460B (cg-RX-API-DMAC7.html)
WO (1) WO1995003270A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA943035B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757408A (fr) * 1969-10-13 1971-04-13 Thomae Gmbh Dr K Nouveaux butanols tertiaires a constituants basiques
FR2279383A1 (fr) * 1974-04-25 1976-02-20 Synthelabo Nouveaux derives tetrasubstitues des alcoylene-diamines, leurs sels, leur preparation et les medicaments qui en contiennent
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US4588728A (en) * 1985-03-27 1986-05-13 Burroughs Wellcome Co. Treatment of drug induced psychosis
US4709094A (en) * 1986-07-10 1987-11-24 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Sigma brain receptor ligands and their use
US4929734A (en) * 1987-03-31 1990-05-29 Warner-Lambert Company Tetrahydropyridine oxime compounds
IT1205124B (it) * 1987-06-05 1989-03-15 Simens Soteta Italiana Medicin Composto attivo nella terapia carciovascolare
US4981870A (en) * 1989-03-07 1991-01-01 Pfizer Inc. Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
US5149817A (en) * 1990-03-05 1992-09-22 Shionogi & Co., Ltd. Teirahydropyridine derivatives
US5116995A (en) * 1990-05-25 1992-05-26 Taisho Pharmaceutical Co., Ltd. Carbazole compounds
JP2935541B2 (ja) * 1990-06-28 1999-08-16 サントリー株式会社 縮合複素環化合物
US5086054A (en) * 1990-07-31 1992-02-04 Sri International Novel arylcycloalkanepolyalkylamines
DE4032767A1 (de) * 1990-10-16 1992-04-30 Basf Ag Phenylpiperidinoylamine und diese enthaltende arzneimittel
ES2086464T3 (es) * 1990-12-19 1996-07-01 Kali Chemie Pharma Gmbh Compuestos de alquilaminoalquil-amina y -eter, asi como procedimientos y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
US5162341A (en) * 1991-02-22 1992-11-10 Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists for treatment of amphetamine abuse
FR2675799B1 (fr) * 1991-04-24 1993-12-24 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
NO950974D0 (no) 1995-03-14
MX9403011A (es) 1995-01-31
FI951277A0 (fi) 1995-03-17
FI951277A7 (fi) 1995-03-17
EP0660819A1 (en) 1995-07-05
EP0660819B1 (en) 1997-10-22
GR3025941T3 (en) 1998-04-30
ES2074946B1 (es) 1996-06-16
ATE159511T1 (de) 1997-11-15
ES2074946A1 (es) 1995-09-16
FI951277L (fi) 1995-03-17
DE69406406T2 (de) 1998-05-20
PH30969A (en) 1997-12-23
NO950974L (no) 1995-03-14
AU7459094A (en) 1995-02-20
AU670716B2 (en) 1996-07-25
DK0660819T3 (da) 1998-01-12
DE69406406D1 (de) 1997-11-27
WO1995003270A1 (en) 1995-02-02
CA2144758A1 (en) 1995-02-02
ZA943035B (en) 1995-05-02
US5561135A (en) 1996-10-01
TW262460B (cg-RX-API-DMAC7.html) 1995-11-11
JPH08503962A (ja) 1996-04-30
NZ271076A (en) 1996-03-26

Similar Documents

Publication Publication Date Title
DE3561199D1 (en) Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient
KR970704702A (ko) 치환된 피리미딘 화합물 및 그의 용도(Substituted Pyrimidine Compounds and Their Use)
KR900007790A (ko) 항-아테롬성 동맥경화증성 디아릴 화합물
KR910002802A (ko) 1,2,3,4-테트라히드로-9-아크리딘아민의 유도체
KR960017663A (ko) 결합 수용체 길항물질
KR940003953A (ko) 1. 4-벤조디옥산 유도체
KR930007914A (ko) 제1위치에 에테르 또는 티오에테르 그룹을 함유하는 프탈라진 및 이의 제조방법
KR930006003A (ko) 이미다졸릴메틸-피리딘류 화합물
KR960702456A (ko) 4-(p-플로오로페닐)-3-[(3,4-(메틸렌디옥시)페녹시)메틸]피페리딘의 n-p-할로벤조일메틸 유도체(n-p-halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]piperidine)
AU655869B2 (en) An amphoteric tricyclic compound
ATE159511T1 (de) Derivate von n,n,n',n'-tetrasubstituierten 1,2- ethylendiamin-verbindungen
KR840001152A (ko) 신규 복소환(複素環) 화합물의 제법
DK0804186T3 (da) Indolditerpenalkaloidforbindelser
KR950011408A (ko) 사이클릭 아민 유도체
KR860003205A (ko) 신규한α-아미노알킬-α-알킬페닐아세토니트릴
KR900014309A (ko) 신규 기관지진경제 및 그의 제조방법
KR910014371A (ko) 인돌일프로판올. 이들의 제조방법. 이들의 용도및 이러한 화합물을 함유하는 제제
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
EP0245004A3 (en) Antihypercholesterolemic compounds
KR910007875A (ko) 도파민 길항제로서의 벤질피롤리딘 유도체
FI953994A0 (fi) Menetelmä (-)-N-metyyli-N-(4-(4-fenyyli-4-asetyyliaminopiperidiini-1-yl)-2-(3,4-diklorofenyyli)butyyli)bentsamidi ja sen farmaseuttisesti hyväksyttäviä suoloja
KR930005621A (ko) 고혈압 치료용 제약 조성물
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
AU7532787A (en) New derivatives of 2,6-piperazinedione, their preparation process and the pharmaceutical compositions containing them
KR900014360A (ko) 피리딘카복실산 아미드 유도체 및 이를 함유하는 약학 조성물

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19950317

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid